ADRIAMYCIN for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where ADRIAMYCIN was used for Breast cancer.
Most Reported Side Effects for ADRIAMYCIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Thrombocytopenia | 28 | 27.2% | 22 | 0 |
| Neutropenia | 26 | 25.2% | 21 | 0 |
| Leukaemia recurrent | 19 | 18.5% | 18 | 0 |
| Febrile neutropenia | 7 | 6.8% | 0 | 3 |
| Sepsis | 7 | 6.8% | 3 | 5 |
| Pneumonia | 6 | 5.8% | 2 | 3 |
Other Indications for ADRIAMYCIN
Blast crisis in myelogenous leukaemia (21)
Mantle cell lymphoma (10)
Plasma cell myeloma (7)
Invasive ductal breast carcinoma (5)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)